Table 1 Comparison according to the type of hysterectomy in patients with endometrial carcinoma with cervical involvement (N = 239)
From: What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
SH, 200 (83.68%) | RH, 39 (16.32%) | Total, 239 | p | |
|---|---|---|---|---|
Age, years¥ | 55.42 (46.9–63.9) | 56.55 (48.7–62.4) | 55.64 (47.2–63.5) | 0.756 |
Weight, kg¥ | 67 (59.8–79.9) | 66 (57–79) | 7 (59–79.8) | 0.643 |
BMI¥ | 28.55 (25.2–33.8) | 27.83 (24.4–32.5) | 28.51 (25.1–33.3) | 0.600 |
Positive cytology§ | 82 (41) | 21 (53.85) | 103 (43.10) | 0.138 |
Histology§ | ||||
Endometrioid | 154 (77) | 23 (58.97) | 177 (74.06) | 0.007 |
Serous papillary | 15 (7.5) | 6 (16.38) | 21 (8.79) | |
Clear cell | 4 (2.0) | 1 (2.56) | 5 (2.09) | |
Mixed | 26 (13.0) | 6 (15.38) | 32 (13.39) | |
Carcinosarcoma | 1 (0.5) | 3 (7.69) | 4 (1.67) | |
Tumor size, mm¥ | 15 (5.3–70.0) | 5 (6–50) | 12 (5.5–65.0) | 0.349 |
Grade§ | ||||
G1 | 9 (4.59) | 4 (10.26) | 13 (5.44) | 0.130 |
G2 | 96 (48.0) | 14 (35.90) | 110 (46.03) | |
G3 | 39 (19.50) | 5 (12.82) | 44 (18.41) | |
Poor prognostic histology | 56 (28) | 16 (41.03) | 72 (30.13) | |
Lymphovascular invasion§ | 134 (72.43) | 31 (83.78) | 165 (74.32) | 0.183 |
Myometrial involvement§ | ||||
Superficial | 5 (2.50) | 1 (2.56) | 6 (2.51) | 0.994 |
< 50% | 52 (26.00) | 10 (25.64) | 62 (25.94) | |
> 50% | 125 (62.50) | 25 (64.10) | 150 (62.76) | |
NA | 18 (9.0) | 3 (7.69) | 21 (8.79) | |
Depth of invasion, mm¥ | 5 (3–12) | 10.5 (5–15) | 6 (3–12.5) | 0.005 |
Depth invasion/thickness rate¥ | 0.48 (0.25–0.67) | 0.52 (0.4–0.87) | 0.5 (0.25–0.92) | 0.028 |
Ovarian involvement§ | 35 (17.50) | 7 (17.95) | 42 (17.57) | 0.946 |
Parametrial involvement§ | 9 (4.50) | 7 (17.95) | 16 (6.69) | 0.002 |
Uterine serosa involvement§ | 18 (9.0) | 5 (12.82) | 23 (9.62) | 0.459 |
Pelvic lymph node involvement, n = 165§ | 55 (41.04) | 15 (48.39) | 70 (42.42) | 0.456 |
Para-aortic lymph node involvement, n = 135§ | 34 (31.78) | 6 (21.43) | 40 (29.63) | 0.286 |
Stage§ | ||||
II | 87 (43.50) | 11 (28.21) | 98 (41.00) | 0.124 |
III | 73 (36.50) | 22 (56.41) | 95 (39.75) | |
IV | 31 (15.5) | 4 (10.26) | 35 (14.64) | |
NA | 9 (4.50) | 2 (5.13) | 11 (4.60) | |
Any radiotherapy§± | 150 (75.00) | 32 (82.05) | 182 (76.2) | 0.345 |
Brachytherapy | 135 (67.50) | 30 (76.92) | 165 (69.04) | 0.244 |
External beam radiotherapy | 124 (62) | 29 (74.36) | 153 (64.02) | 0.141 |
Chemotherapy§ | 107 (53.50) | 22 (56.41) | 129 (53.97) | 0.739 |
Recurrence§ | 46 (23.00) | 11 (28.21) | 57 (23.85) | 0.485 |
Death§ | 35 (17.50) | 5 (12.82) | 40 (16.74) | 0.474 |